ATE203519T1 - Chinolinderivate als antimalariamittel - Google Patents
Chinolinderivate als antimalariamittelInfo
- Publication number
- ATE203519T1 ATE203519T1 AT96938130T AT96938130T ATE203519T1 AT E203519 T1 ATE203519 T1 AT E203519T1 AT 96938130 T AT96938130 T AT 96938130T AT 96938130 T AT96938130 T AT 96938130T AT E203519 T1 ATE203519 T1 AT E203519T1
- Authority
- AT
- Austria
- Prior art keywords
- antimalariatic
- agents
- quinoline derivatives
- derivatives
- quinoline
- Prior art date
Links
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title abstract 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 1
- 201000004792 malaria Diseases 0.000 abstract 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Dental Preparations (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH325095 | 1995-11-16 | ||
| PCT/EP1996/004866 WO1997018193A1 (en) | 1995-11-16 | 1996-11-07 | Antimalarial quinolin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE203519T1 true ATE203519T1 (de) | 2001-08-15 |
Family
ID=4251904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96938130T ATE203519T1 (de) | 1995-11-16 | 1996-11-07 | Chinolinderivate als antimalariamittel |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5948791A (de) |
| EP (1) | EP0876346B1 (de) |
| JP (1) | JP3034609B2 (de) |
| KR (1) | KR100263802B1 (de) |
| CN (1) | CN1166639C (de) |
| AT (1) | ATE203519T1 (de) |
| AU (1) | AU718932B2 (de) |
| BR (1) | BR9611727A (de) |
| CA (1) | CA2237997A1 (de) |
| DE (1) | DE69614149T2 (de) |
| DK (1) | DK0876346T3 (de) |
| ES (1) | ES2162110T3 (de) |
| GR (1) | GR3037018T3 (de) |
| MX (1) | MX9803827A (de) |
| PT (1) | PT876346E (de) |
| TR (1) | TR199800854T2 (de) |
| WO (1) | WO1997018193A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1261340B1 (de) | 1999-07-13 | 2009-05-13 | Alpha Research Group, LLC | Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit |
| US20040229908A1 (en) * | 1999-07-13 | 2004-11-18 | Jodi Nelson | Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias |
| FR2807433B1 (fr) * | 2000-04-06 | 2002-09-20 | Centre Nat Rech Scient | Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques |
| GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| WO2003070244A1 (en) * | 2002-02-22 | 2003-08-28 | Abbott Laboratories | Antagonist of melanin concentrating hormone and their uses |
| US6818772B2 (en) | 2002-02-22 | 2004-11-16 | Abbott Laboratories | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| US7084157B2 (en) * | 2002-05-17 | 2006-08-01 | Rajeev Raut | Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation |
| US20060014786A1 (en) * | 2002-05-17 | 2006-01-19 | Rajeev Raut | Opthalmic pharmaceutical compositions and methods for treating ocular inflammation |
| US7108992B2 (en) * | 2002-11-27 | 2006-09-19 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
| US6916627B2 (en) * | 2002-11-27 | 2005-07-12 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
| US7968539B2 (en) | 2005-02-17 | 2011-06-28 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Portland State University | Quinoline derivatives and uses thereof |
| WO2007059372A2 (en) * | 2005-11-09 | 2007-05-24 | St. Jude Children's Research Hospital | Use of chloroquine to treat metabolic syndrome |
| FR2902100A1 (fr) * | 2006-06-13 | 2007-12-14 | Sanofi Aventis Sa | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique |
| AU2009316721A1 (en) | 2008-11-18 | 2010-05-27 | Oregon Health & Science University | Compounds for treating parasitic disease |
| GB201206280D0 (en) * | 2012-04-10 | 2012-05-23 | Univ Dundee | Anti-malarial agents |
| JPWO2015133280A1 (ja) * | 2014-03-03 | 2017-04-06 | 公立大学法人名古屋市立大学 | 抗マラリア活性化合物及び抗マラリア薬 |
| WO2022112596A1 (en) | 2020-11-30 | 2022-06-02 | Cellectis Sa | Use of aminoquinoline compounds for higher gene integration |
| WO2022191092A1 (ja) * | 2021-03-12 | 2022-09-15 | 国立大学法人東北大学 | キノリン化合物、ｈｎｍｔ阻害剤、及びａｄｈｄ、ナルコレプシー又はアルツハイマーの予防・治療剤 |
| EP4608809A2 (de) * | 2022-10-28 | 2025-09-03 | The United States Government as represented by the Department of Veterans Affairs | 4-aminochinoline zur behandlung von gegen mehrere arzneimittel resistenter malaria |
| WO2025244856A1 (en) * | 2024-05-24 | 2025-11-27 | Oregon Health & Science University | Methods and compositions relating to elq compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2816893A (en) * | 1957-12-17 | Improvements in or relating to | ||
| US2901484A (en) * | 1957-03-04 | 1959-08-25 | Abbott Lab | Bis-quinoliniums |
| NL278921A (de) * | 1961-05-26 | |||
| US5510356A (en) * | 1991-10-03 | 1996-04-23 | University Of Nebraska Board Of Regents | Bisquinolines and processes for their production and use to treat malaria |
| PT765313E (pt) * | 1994-06-17 | 2003-11-28 | Hoffmann La Roche | Derivados de n,n'-bis(quinolin-4-il)-diamina a sua preparacao e a sua utilizacao como agentes anti-malaria |
| WO1995035288A1 (en) * | 1994-06-17 | 1995-12-28 | F.Hoffmann-La Roche Ag | Bisquinolines for the treatment of malaria |
-
1996
- 1996-11-07 DE DE69614149T patent/DE69614149T2/de not_active Expired - Fee Related
- 1996-11-07 KR KR1019980703674A patent/KR100263802B1/ko not_active Expired - Fee Related
- 1996-11-07 BR BR9611727A patent/BR9611727A/pt not_active Application Discontinuation
- 1996-11-07 WO PCT/EP1996/004866 patent/WO1997018193A1/en not_active Ceased
- 1996-11-07 AT AT96938130T patent/ATE203519T1/de not_active IP Right Cessation
- 1996-11-07 PT PT96938130T patent/PT876346E/pt unknown
- 1996-11-07 CN CNB961983582A patent/CN1166639C/zh not_active Expired - Fee Related
- 1996-11-07 EP EP96938130A patent/EP0876346B1/de not_active Expired - Lifetime
- 1996-11-07 AU AU75669/96A patent/AU718932B2/en not_active Ceased
- 1996-11-07 TR TR1998/00854T patent/TR199800854T2/xx unknown
- 1996-11-07 ES ES96938130T patent/ES2162110T3/es not_active Expired - Lifetime
- 1996-11-07 JP JP9518553A patent/JP3034609B2/ja not_active Expired - Fee Related
- 1996-11-07 DK DK96938130T patent/DK0876346T3/da active
- 1996-11-07 CA CA002237997A patent/CA2237997A1/en not_active Abandoned
- 1996-11-12 US US08/747,173 patent/US5948791A/en not_active Expired - Fee Related
-
1998
- 1998-05-14 MX MX9803827A patent/MX9803827A/es unknown
-
2001
- 2001-10-25 GR GR20010401889T patent/GR3037018T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69614149T2 (de) | 2002-03-14 |
| AU7566996A (en) | 1997-06-05 |
| TR199800854T2 (xx) | 1998-08-21 |
| JPH11500749A (ja) | 1999-01-19 |
| EP0876346A1 (de) | 1998-11-11 |
| EP0876346B1 (de) | 2001-07-25 |
| US5948791A (en) | 1999-09-07 |
| DE69614149D1 (de) | 2001-08-30 |
| KR100263802B1 (ko) | 2001-01-15 |
| JP3034609B2 (ja) | 2000-04-17 |
| CN1166639C (zh) | 2004-09-15 |
| ES2162110T3 (es) | 2001-12-16 |
| KR19990067646A (ko) | 1999-08-25 |
| CA2237997A1 (en) | 1997-05-22 |
| CN1202155A (zh) | 1998-12-16 |
| AU718932B2 (en) | 2000-05-04 |
| BR9611727A (pt) | 1999-05-25 |
| GR3037018T3 (en) | 2002-01-31 |
| MX9803827A (es) | 1998-09-30 |
| WO1997018193A1 (en) | 1997-05-22 |
| PT876346E (pt) | 2002-01-30 |
| DK0876346T3 (da) | 2001-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE203519T1 (de) | Chinolinderivate als antimalariamittel | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| ES2184149T3 (es) | Paclitaxeles 6-tio sustituidos. | |
| HN1995009160A (es) | Derivados de cicloalcano indol y azaindol | |
| ATA204894A (de) | Isochinoline | |
| DE69925133D1 (de) | Pyrrolobenzodiazepine | |
| ES2178093T3 (es) | Derivados de epotilon y su preparacion. | |
| HN1996000082A (es) | Compuestos de quinolina y quinozssolina utiles en terapia. | |
| DE69530606D1 (de) | Verwendung von pramipexole als neuroschutzmittel | |
| BR9808491A (pt) | Compostos calcilìticos | |
| BR9711586A (pt) | Compostos e uso dos mesmo | |
| ATE233274T1 (de) | Oxyiminopregnancarbolactone | |
| ATE167670T1 (de) | N-alkylthiopolyaminderivate als radioprotektive mittel | |
| DE69814894D1 (de) | Isochinolin derivate als urokinase inhibitoren | |
| PY0101314A (es) | Compuestos farmaceuticos | |
| NO980296L (no) | Forbedrede terapeutiske midler | |
| TR200000697T2 (tr) | İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| ES2192610T3 (es) | Aminouracilos substituidos. | |
| FI956150A7 (fi) | Isokinoliinijohdannaisia terapeuttisina aineina | |
| ATE204255T1 (de) | Carbostyrilderivate als antithrombotische mittel | |
| DE59608611D1 (de) | Topische aciclovir-zubereitung | |
| DK0720597T3 (da) | Triarylethylenderivater til terapeutisk anvendelse | |
| ATE250340T1 (de) | 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele | |
| FI956016A7 (fi) | 1,2-silloitettujen 1,4-dihydropyridiinien käyttö lääkeaineina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |